Enhancement of anti-tumor immunity in immunogenic and immune-refractory RAS mutant tumors with tri-complex RAS(ON) inhibitors

Blaj, C; Menard, M; Shifrin, NT; Chen, K; Chow, C; Courtney, H; Kumamoto, A; Velilla, T; Evans, JW; Lawrence, L; Vonmelchert, B; Kwok-Parkhill, A; Singh, M; Smith, JA; Quintana, E

EUROPEAN JOURNAL OF CANCER, 2022; 174 (): S59